vimarsana.com

Latest Breaking News On - Icecure medical - Page 3 : vimarsana.com

Game-Changing Tumor Freezing Technology Has The Potential To Offer Women First-Ever Minimally Invasive Alternative To Breast Lumpectomy Surgery

IceCure Medical Ltd. ICCM, which is set to submit results from the largest cryoablation study of its kind to the FDA, may set a new standard of care for…

HC Wainwright Reiterates Buy Rating for IceCure Medical (NASDAQ:ICCM)

HC Wainwright Reiterates Buy Rating for IceCure Medical (NASDAQ:ICCM)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

IceCure Medical (NASDAQ:ICCM) Earns Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of IceCure Medical (NASDAQ:ICCM – Free Report) in a research note published on Thursday, Benzinga reports. They currently have a $3.00 target price on the stock. Separately, Alliance Global Partners increased their price target on shares of IceCure Medical from $1.90 to $2.90 and gave the stock […]

IceCure Medical (NASDAQ:ICCM) Releases Earnings Results, Beats Estimates By $0 01 EPS

IceCure Medical (NASDAQ:ICCM – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.01, Yahoo Finance reports. IceCure Medical had a negative net margin of 535.84% and a negative return on equity of 77.41%. The company had […]

IceCure Medical (NASDAQ:ICCM) Releases Quarterly Earnings Results, Beats Estimates By $0 01 EPS

IceCure Medical (NASDAQ:ICCM – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.01, Yahoo Finance reports. The business had revenue of $1.26 million during the quarter. IceCure Medical had a negative return on equity of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.